Boston Scientific today announced a catheter development and commercialization deal with Siemens Healthineers.
A 76-year-old man on dabigatran for rate-controlled atrial fibrillation had follow-up transthoracic echocardiography (TTE) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback